Impact News +++ ANLEIHEN-Woche #KW34 – 2025: Energiekontor, JDC, The Platform Group, Aream, LEEF, Dt. Rohstoff,... (Anleihen-Finder) +++ PLATFORM GROUP Aktie +4,84%

ELEDON Aktie

>ELEDON Aktienkurs

2.22 EUR (Tradegate)

Ask: 2.32 EUR / 720 Stück

Bid: 2.12 EUR / 780 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

ELEDON Aktie über LYNX handeln

Intraday

1 Jahr

>ELEDON Performance

1 Woche: +4,7%

1 Monat: -29,3%

3 Monate: -17,8%

6 Monate: -45,9%

1 Jahr: -17,8%

laufendes Jahr: -48,1%

>ELEDON Aktie

Name:

ELEDON PHARMACEUT.DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US28617K1016 / A2QL00

Symbol/ Ticker:

2TK (Frankfurt) / ELDN (NASDAQ)

Kürzel:

FRA:2TK, ETR:2TK, 2TK:GR, NASDAQ:ELDN

Index:

Webseite:

https://eledon.com/

Profil:

Eledon Pharmaceuticals Inc. is a clinical-stage bi..
>Volltext..

Marktkapitalisierung:

134.64 Mio. EUR

Unternehmenswert:

91.31 Mio. EUR

Umsatz:

EBITDA:

-75.29 Mio. EUR

Nettogewinn:

-6.78 Mio. EUR

Gewinn je Aktie:

0.06 EUR

Schulden:

0.69 Mio. EUR

Liquide Mittel:

4.93 Mio. EUR

Operativer Cashflow:

-55.38 Mio. EUR

Bargeldquote:

7.84

Umsatzwachstum:

Gewinnwachstum:

95.64%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ELEDON

Letzte Datenerhebung:

23.08.25

>ELEDON Kennzahlen

Aktien/ Unternehmen:

Aktien: 59.88 Mio. St.

Frei handelbar: 93.24%

Leerverk. Aktien: 7.32%

Rückkaufquote: -54.54%

Mitarbeiter: 31

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 248.59%

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: 3.25

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -5.95%

Eigenkaprendite: -16.2%

>ELEDON Peer Group

Es sind 601 Aktien bekannt.

>ELEDON Chart & Kurs - NASDAQ

>ELEDON News

15.08.25 - 04:12	Eledon Posts Narrower Loss in Q2 (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

14.08.25 - 23:21	Eledon Pharmaceuticals GAAP EPS of -$0.13 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.08.25 - 22:24	Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results (GlobeNewswire EN)
	Eledon Pharmaceuticals Reports Second Quarter 2025 Operating and Financial Results...

06.08.25 - 22:03	Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation (GlobeNewswire EN)
	Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation...

17.07.25 - 22:03	Updated Data from Eledon Pharmaceuticals′ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025 (GlobeNewswire EN)
	Updated Data from Eledon Pharmaceuticals' Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at WTC 2025...

09.07.25 - 14:33	Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes (GlobeNewswire EN)
	Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova's Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova's Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabetes...

25.06.25 - 22:03	Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City (GlobeNewswire EN)
	Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City...

23.05.25 - 21:00	What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock (Zacks)
	Eledon Pharmaceuticals (ELDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

15.05.25 - 00:09	Eledon Pharmaceuticals GAAP EPS of -$0.08 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.05.25 - 22:03	Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results (GlobeNewswire EN)
	Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results...

20.03.25 - 21:42	Eledon Pharmaceuticals GAAP EPS of -$0.75 misses by $0.04 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

20.03.25 - 21:03	Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results (GlobeNewswire EN)
	Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results...

04.03.25 - 22:09	Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference (GlobeNewswire EN)
	Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference...

07.02.25 - 16:03	Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human (GlobeNewswire EN)
	Eledon Announces Tegoprubart Use as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human...

29.01.25 - 22:09	Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference (GlobeNewswire EN)
	Eledon Pharmaceuticals to Participate in Guggenheim SMID Cap Biotech Conference...

13.01.25 - 13:03	Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook (GlobeNewswire EN)
	Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook...

13.11.24 - 10:00	Eledon Pharmaceuticals GAAP EPS of -$0.32 misses by $0.02 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.11.24 - 22:06	Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results (GlobeNewswire EN)
	Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results...

29.10.24 - 13:57	Eledon Pharmaceuticals prices 18.36M shares at $3.65 in underwritten offering (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

29.10.24 - 12:48	Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire EN)
	Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Ein Politiker verschweigt oft auch das, was er nicht weiß. - Dr. Fritz P. Rinnhofer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram